Cargando…
Analysis of the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk
INTRODUCTION: Results conflict on the association between the XRCC2 rs3218536 polymorphism and ovarian cancer risk, despite wide-ranging investigations. This meta-analysis examines whether the XRCC2 rs3218536 polymorphism is associated with ovarian cancer risk. MATERIAL AND METHODS: Eligible case-co...
Autores principales: | Yuan, Cunzhong, Liu, Xiaoyan, Li, Rongrong, Yan, Shi, Kong, Beihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7212224/ https://www.ncbi.nlm.nih.gov/pubmed/32399118 http://dx.doi.org/10.5114/aoms.2020.94657 |
Ejemplares similares
-
Associations between XRCC2 rs3218536 and ERCC2 rs13181 polymorphisms and ovarian cancer
por: Zhang, Wei, et al.
Publicado: (2016) -
Analyzing Association of the XRCC3 Gene Polymorphism with Ovarian Cancer Risk
por: Yuan, Cunzhong, et al.
Publicado: (2014) -
Association of XRCC2 rs3218536 Polymorphism with Susceptibility of Breast and Ovarian Cancer: A Systematic Review and Meta-Analysis
por: Kamali, Mahdieh, et al.
Publicado: (2017) -
XRCC2 rs3218536 polymorphism decreases the sensitivity of colorectal cancer cells to poly(ADP-ribose) polymerase 1 inhibitor
por: XU, KAIWU, et al.
Publicado: (2014) -
The MTDH (−470G>A) Polymorphism Is Associated with Ovarian Cancer Susceptibility
por: Yuan, Cunzhong, et al.
Publicado: (2012)